Misplaced Pages

Thioacetazone

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by BogBot (talk | contribs) at 21:41, 30 August 2011 (populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 21:41, 30 August 2011 by BogBot (talk | contribs) (populated new fields in {{drugbox}} and reordered per bot approval. Report errors and suggestions to User_talk:BogBot)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
It has been suggested that Conteben be merged into this article. (Discuss) Proposed since June 2011.

{{Drugbox | verifiedrevid = 443222189 | IUPAC_name = N-{4-phenyl}acetamide | image = Thioacetazone.svg

| tradename = | Drugs.com = International Drug Names | routes_of_administration = Oral

| CAS_number = 104-06-3 | ATC_prefix = J04 | ATC_suffix = AM04 | PubChem = 9568512 | DrugBank_Ref = | ChemSpiderID_Ref = | ChemSpiderID = 7843221 | UNII_Ref = | UNII = MMG78X7SSR | KEGG_Ref = | KEGG = D08584

| C=10 | H=12 | N=4 | O=1 | S=1 | molecular_weight = 236.3 | smiles = O=C(Nc1ccc(cc1)\C=N\NC(=S)N)C | InChI = 1/C10H12N4OS/c1-7(15)13-9-4-2-8(3-5-9)6-12-14-10(11)16/h2-6H,1H3,(H,13,15)(H3,11,14,16)/b12-6+ | InChIKey = SRVJKTDHMYAMHA-WUXMJOGZBW | StdInChI_Ref = | StdInChI = 1S/C10H12N4OS/c1-7(15)13-9-4-2-8(3-5-9)6-12-14-10(11)16/h2-6H,1H3,(H,13,15)(H3,11,14,16)/b12-6+ | StdInChIKey_Ref = | StdInChIKey = SRVJKTDHMYAMHA-WUXMJOGZSA-N | synonyms = N-phenyl]acetamide }} Thioacetazone(INN and BAN) is also called thiocetazone, thiacetazone, thiosemicarbazone, benzothiozane or amithiozone(USAN); abbreviated T.

Thioacetazone is used in the treatment of tuberculosis; it has only weak activity against Mycobacterium tuberculosis and is only useful in preventing resistance to more powerful drugs like isoniazid and rifampicin. It is never used on its own to treat tuberculosis; it is used in a similar way to ethambutol. Thioacetazone is the only anti-TB drug that is ineffective when given intermittently.

There is no advantage to using thioacetazone if the regimen used already contains ethambutol, but many countries in sub-Saharan Africa still use thioacetazone because it is extremely cheap. Use of thioacetazone is declining because it can cause severe (sometimes fatal) skin reactions in HIV positive patients.

References

  1. Rieder HL, Arnadottir T, Trebucq A, Enarson DA (2001). "Tuberculosis treatment: dangerous regimens?". Int J Tuberc Lung Dis. 5 (1): 1–3. PMID 11263509.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  2. Nunn P, Porter J, Winstanley P (1993). "Thiacetazone—avoid like poison or use with care?". Trans R Soc Trop Med Hyg. 87 (5): 578–82. doi:10.1016/0035-9203(93)90096-9. PMID 7505496.{{cite journal}}: CS1 maint: multiple names: authors list (link)


Stub icon

This systemic antibiotic-related article is a stub. You can help Misplaced Pages by expanding it.

Categories: